LB Pharmaceuticals, Inc. (LBRX)

41.37 -1.62 (-3.77%) USD  |  NASDAQ  |  Sep 22, 12:03
More

LB Pharmaceuticals Total Long Term Debt (Quarterly) : 4.373M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for LBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 4.373M
March 31, 2026 2.74M
December 31, 2025 2.839M
September 30, 2025 2.936M
June 30, 2025 0.00
March 31, 2025 0.00
Date Value
December 31, 2024 3.216M
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
March 31, 2023 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. 1.130B
Neumora Therapeutics, Inc. 52.95M
ANI Pharmaceuticals, Inc. 610.49M
Corcept Therapeutics, Inc. 7.504M
Veru, Inc. 1.908M